Ebola outbreak: Tekmira working on life-saving Ebola drug

3,139 views · Published 11 September 2014 · 1:35 · Indexed 31 October 2026

Channel: News Direct · 2014 · News & Politics

Watch on YouTube

As scientists race around the clock to develop a treatment for Ebola, which has already killed 1,013 and infected 1,848 in West Africa, one company in Canada has developed a therapy that holds promise.

It’s a gene-silencing drug developed by Tekmira Pharmaceuticals, and it has already proven effective in monkeys.

The study by Tekmira started in 2010 when researchers injected a lethal dose of the deadly Zaire species of Ebola virus into Chinese rhesus macaques.

Researchers then used a synthetic version of RNA called siRNA and a protein called Argonaute inside fat molecules and injected them into the macaques to target three Ebola genes which are responsible for virus replication. 

The molecules worked by binding to the RNA produced by the Ebola virus, blocking its ability to replicate by making disease-causing proteins.

TMK-Ebola has been effective in animal trials, but tests haven’t been carried out on humans due to safety concerns. In July, the FDA placed a clinical hold on the company's TKM-Ebola Phase 1 healthy volunteer study, according to Reuters.

There are currently no licensed drugs or vaccines to treat Ebola.

More from this channel